Pfizer Delivers On Biosimilars Strategy

Reports Biosimilars Sales Up By 19% To $911m In 2019

 
• By Jessica Merrill and Dave Wallace
  
The key of success close to open the door.
Has Pfizer found the key to success in biosimilars? • Source: Shutterstock

More from Earnings

More from Business